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Abstract 
Background: Recurrent thoracotomies regardless of the cause are not a rare occurrence. 
However, each thoracotomy results in adhesion to some extent. This adhesions increase 
morbidity and mortality presents a significant inconvenience for surgeons and prolongs 
the length of operations.  
Objective: We investigated the efficacy of Prevadh®, an anti-adhesion agent to prevent 
intrapleural adesions following thoracotomy in a rat model. 
Methods: Twenty male adult Wistar Albino rats were divided into a sham group (Group 
A, n = 4), a control group (Group B, n = 8), and a study group (Group C, n = 8). Only left 
thoracotomy was performed in Group A. Group B underwent left thoracotomy, induc-
tion  of  adhesion,  and  1  ml  saline  solution  was  administered  to  the  thoracic  cavity. 
However, in Group C underwent left thoracotomy, induction of adhesion, and Prevadh® 
was placed between the pleura and the lung. The rats were sacrificed on day 21, and 
adhesions were analyzed using both macroscopic and histopathological methods. The 
results  were  statistically  analyzed.  A  value  of  P<0.05  was  considered  statistically 
significant. 
Results:  Mean  lengths  of  adhesion  differed  statistically  significantly  among  all  three 
groups, while mean intensity of adhesion differed between Group A and Group B, and 
between Group B and Group C (P>0.05). There was also a statistically significant differ-
ence between Group A and Group C in mesothelium proliferation score (P>0.05). No 
statistically  significant  differences  were  found  among  the  groups  in  terms  of  pleural 
thickness, macrophage and mononuclear cell infiltration (P>0.05).   
Conclusions:  Prevadh®  was  shown  in  a  rat  model  to  effectively  prevent 
post-thoracotomy adhesions. 
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INTRODUCTION 
There are only a few studies on intrapleural ad-
hesions  following  thoracotomy  [1],  whereas  many 
clinical and empirical studies have been conducted to 
investigate  adhesions  that  occur  after  abdominal 
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surgeries [2, 3]. This is because adhesions following 
abdominal  surgery  leads  to  serious  complications, 
while it is even a desired effect in thoracic surgery, 
since  adhesions  that  develop  between  visceral  and 
parietal pleura’s after thoracotomy provides a natural 
pleurodesis  effect  by  preventing  postoperative  air 
leakages and pleural effusion. However, these adhe-
sions  may  cause  significant  problems  in  recurrent 
thoracotomies.  
Today,  recurrent  thoracotomies  are  being  seen 
with  increasing  frequency  particularly  in  metastatic 
lung cancer, unilateral metachronous lung cancer, and 
recurrent pneumothorax. More than tree resections in 
a single patient are not a rare condition [4, 5]. Signifi-
cant adhesions occur in these patients, especially be-
hind the thoracotomy incision line. These scar tissues 
put surgeons in a difficult position, make it difficult to 
free  the  lung  and  to  access  to  hilus,  and  causes 
bleeding and prolonged air leaks [6, 7]. This results 
increased operation times, morbidity and mortality.  
Anti-adhesion barriers are rarely used in thoracic 
surgeries, and only a few experimental studies have 
been  performed  on  this  subject.  Tanaka  et  al.  have 
shown  that  adhesions  may  be  avoided  following 
thoracotomy by using a hyaluronate-based absorbable 
membran in rats [6]. Also, Getman et al. achieved the 
same effect by using haemostatic membrane [7].  
The  present  study  investigates  the  efficacy  of 
Prevadh® (Tyco/Sofradim, Trevoux, French), which 
is  an  anti-adhesion  barrier  composed  of  collagen, 
polyethylene  glycol  and  glycerol  following  thora-
cotomy in a rat model. The purpose of this experi-
mental study is to determine the safety and efficacy of 
this substance before it is studied in clinical trials in 
humans.  
METHODS  
Population 
A  prospective,  randomized,  double-blinded, 
controlled, experimental study was conducted with 20 
male adult Wistar albino rats from the same colony 
weighting 250–300 g. The rats were obtained from the 
Experimental  Animals  Laboratory  of  Dokuz  Eylul 
University Faculty of Medicine. The purpose of using 
rats is easy availability, safety, and the high ratio of 
repeating the experiment. 
Design 
The  rats  were  randomly  divided  into  three 
groups: Group A: Sham (n = 4) and Group B: Control 
(n = 8), Group C: Study (n = 8). They were maintained 
under  specific  pathogen-free  conditions  to  avoid 
infections and housed separately in a light-controlled 
room with a 12:12 h light–dark cycle. The temperature 
(22±0.5ºC) and relative humidity (65–70%) were kept 
constant. Standard laboratory rodent chow and water 
were  available  ad  libitum.  They  were  deprived  of 
food  for  12  h  before  the  experiment  but  had  free 
access to water.  
All  of  the  rats  were  anesthetized  by 
administering  ketamine  hydrochloride  (Ketalar, 
Pfizer, Turkey) 40 mg/kg and xylazine hydrochloride 
(Rompun, Bayer, Turkey) 4 mg/kg intraperitoneally. 
During  the  procedure,  additional  doses  were 
administered  if  necessary.  The  rats  were  intubated 
with 16G plastic catheters. During intubation, the rats 
were  administered  0.1  mg/kg  intravenous  vecu-
ronium  bromide  as  neuromuscular  blocker  and, 
throughout  the  operation,  they  received  ventilation 
support in volume-control mode, which provided 90 
respiration counts and a volume of 15-20 ml/kg per 
minute (Hugo Sacs, Rodent Ventilator, Germany). The 
body  temperature  was  maintained  at  37.0ºC  with  a 
heat pad to prevent the effects of hypothermia and to 
maintain  the  stability  of  hemodynamic  parameters. 
They were placed in right decubitus position, the op-
eration  site  was  disinfected,  shaved,  and  particular 
attention was paid for asepsis and antisepsis during 
operation.  Left  posterolateral  thoracotomy  from  the 
4th intercostal space was performed in all groups.   
Only thoracotomy was performed in Group A. 
Group B underwent thoracotomy, induction of adhe-
sion, and 1 ml normal saline solution was adminis-
tered  to  the  thoracic  cavity  (Figure  1A).  However, 
Group C underwent thoracotomy, induction of adhe-
sion, and Prevadh® sized 3 x 3 cm. was placed be-
tween the pleura and the lung (Figure 1B). All three 
groups  were  checked  against  bleeding,  air  leakage, 
and  the  layers  were  closed  appropriately.  The  rats 
were  extubated  after  they  resumed  spontaneous 
breathing, and were kept in separate cages. No anti-
biotics were administered during or after surgery. The 
rats received intramuscular morphine HCL 0.1 mg/kg 
in every 12 hours during the first 24 hours. The rats 
were sacrificed using ether at lethal doses on day 21, 
when wound healing was complete and anti-adhesion 
barrier was completely absorbed.   
Induction of intrapleural adhesion model  
Adhesion  model  was  generated  based  on  the 
model in the study by Tanaka et al., which was modi-
fied  in  this  study  [6].  The  parietal  pleura  was 
scratched using spanch after the procedure described 
above.  Later,  visceral  pleura  was  abraded  with  dry 
spanch first, followed by spanch wetted with 0.1 ml 
iodine, avoiding air leakage and bleeding.  Int. J. Med. Sci. 2011, 8 
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Macroscopic examination 
Recurrent thoracotomy was performed at the 8th 
or  9th  intercostal  space  and  intrapleural  adhesions 
were analyzed macroscopically (Figure 1C and 1D). 
Adhesions were scored as shown below: A) Length of 
adhesion:  The  length  of  adhesion  before  the  first 
thoracotomy incision (mm). B) Scoring of the intensity 
of  adhesion  between  the  parietal  pleura 
and  the  lung:  1:  No  adhesion,  2:  Loose: 
Which can be removed with blunt dissec-
tion, 3: Moderate: Some of which requires 
sharp  dissection,  4:  Severe:  All  of  which 
requires sharp dissection. 
Microscopic examination  
The  chest  wall  was  removed  en bloc 
with adhered lung. Following fixation with 
buffered formaldehyde 10% and decalcification with 
Planko-Rychlo  solution,  the  chest  wall  was  incised 
with 5 mm spaces such that the chest wall will posi-
tion perpendicular to the ribs. Light microscopy was 
used  for  histopathological  analysis  of  the 
Hematoxylin-Eosin  stained  sections  (Figure  2A  and 
2B). 
 
 
Figure 1. Macroscopic images of the rats. A: 
Appearance  of  the  visceral  pleura  after 
abrasion with dry and iodinated spanch. B: 
Placement  of  a  3  x  3  cm  anti-adhesion 
membrane (Prevadh®) in the adhesion mod-
el-induced rat between the lung and parietal 
pleura.  C:  Recurrent  thoracotomy  of  the 
Group B at the 9
th intercostal space after 21 
days and image of the adhered lung and ad-
hesions across the previous thoracotomy line. 
D: Image of the recurrent thoracotomy after 
21  days  in  the  Group  C  with  anti-adhesion 
membrane installed.  
 
 
 
 
Figure 2. Microscopic images of the rats. A: Lung tissue adhered to the thoracotomy line in the Group B (Hematox-
ylin-Eosin x40 magnification). B: In the Group C, complete mesothelial regeneration and smooth pleural surface were 
determined (Hematoxylin-Eosin x200 magnification). 
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Assessment of changes in parietal pleura  
Scoring  mesothelium  cell  proliferation:  This 
variable  demonstrates  the  integrity  of  the  mesothe-
lium tissue (x200 magnification). 1: Pleural surface is 
completely covered with  mesothelium cells, 2: Fifty 
percent of pleural surface is covered with mesothe-
lium cells, 3: Less than 50% of the pleural surface is 
covered  with  mesothelium  cells,  and  4:  Absence  of 
mesothelium tissue. 
Infiltration score for mononuclear inflammatory 
cells (MICs): In the collagen layer under the adhered 
lung tissue or over the pleural surface (x400 magnifi-
cation). 1: Mild: Almost  no MIC, 2: Moderate: MIC 
count < 100, 3: Marked: MIC count > 100. 
Infiltration score for macrophages in the collagen 
tissue (x400 magnification). 1: Mild: Almost no mac-
rophages, 2: Moderate: Macrophage count  < 100, 3: 
Marked: Macrophage count > 100. 
Ethics 
The study was approved by a local ethics board 
of  Dokuz  Eylul  University  Faculty  of  Medicine, 
Animal Care and Use Committee. The rats were cared 
for in accordance with the Guide for the Care and Use of 
Laboratory Animals.  
Statistical analysis 
The  results  were  recorded  by  the  principal 
investigator  and  analyzed  statistically  upon 
completion of the study. The statistical analysis was 
performed with SPSS software, version 15 (SPSS, Inc., 
Chicago,  IL).  Clinical  data  were  expressed  as  the 
median  ±  the  standard  error  of  mean 
(minimum-maximum).  The  non-parametric  Kruskal 
Wallis variance analysis was used to determine any 
differences in the studied parameters among groups, 
and Mann-Whitney U test was used to find out the 
source of difference in cases where a significant dif-
ference  was  noted  among  the  groups.  P  value  less 
than 0.05 was considered statistically significant. 
RESULTS 
All 20 rats survived the time to the study start 
date  and  the  surgical  procedure.  The  groups  were 
analyzed  both  macroscopically  and  microscopically. 
Using  the  findings  of  these  analyses,  the  rats  were 
further analyzed for the length of adhesion, intensity 
of adhesion score, pleural thickness, mesothelial cell 
proliferation  score,  MIC  infiltration  score  and  mac-
rophage infiltration score.  
Mean length of adhesion in Group A and B were 
3.0±2.2 and 10.0±2.0, respectively, while it was 0.0 cm 
in Group C. Mean intensity of adhesion scores in the 
Group A, Group B, and Group C were 1.5±1.0, 3.4±0.7, 
and 1.0±0.0, respectively (Table 1).  
 
 
Table 1: Comparative lengths and intensities of adhe-
sion among Groups A, B and C  
Number of rats  Length of adhesion 
(mm) 
Intensity of 
adhesion score* 
Group A 
   (n=4) 
1  3  2 
2  5  2 
3  0  0 
4  4  2 
Group B 
   (n=8) 
1  9  4 
2  8  4 
3  9  2 
4  11  3 
5  10  4 
6  11  4 
7  14  3 
8  8  3 
Group C  
   (n=8) 
 
1  0  1 
2  0  1 
3  0  1 
4  0  1 
5  0  1 
6  0  1 
7  0  1 
8  0  1 
*1: No adhesion, 2: Loose: Which can be removed with blunt dis-
section, 3: Moderate: Some of which requires sharp dissection, 4: 
Severe: All of which requires sharp dissection. 
 
 
Mean  pleural  thickness  values  were  306.3  ± 
199.4, 357.5 ± 289.2 and 226.3 ± 141.8 for Group A, 
Group  B,  and  Group  C,  respectively  (Table  2).  The 
three groups did not differ significantly in terms of 
pleural thickness (P>0.05).  
Mean mesothelial cell proliferation scores were 
1.1±0.3, 2.7±1.2, and 1.6±0.4 in Group A, Group B, and 
Group C, respectively (Table 3), and statistically sig-
nificant difference was identified between the Group 
A and Group C (P<0.05). Mesothelial cell proliferation 
was  reduced  in  the  Group  B  while  mesothelial  cell 
proliferation could reach to certain level in the Group 
A and Group C.  
Mean MIC infiltration score was 1.3±0.4, 1.7±0.7, 
and 1.3±0.3 for Group A, Group B, and Group C, re-
spectively.  Mean  macrophage  infiltration  score  was 
1.3±0.3, 1.5±0.3, and 1.4±0.5 for Group A, Group B, 
and Group C, respectively (Table 3). No statistically 
significant difference was noted among the groups for 
these two parameters (P>0.05) (Table 4).  Int. J. Med. Sci. 2011, 8 
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Table 2: Measurements of pleural thickness where ad-
hesions were most intense in Groups A, B and C 
 Number of rats  Pleural thickness (µm) 
Group A 
(n=4) 
1  350–200 
2  50–50 
3  500–250 
4  700–350 
Group B 
(n=8) 
1  200–180 
2  150–280 
3  200–150 
4  350–120 
5  550–120 
6  1300–800 
7  350–140 
8  380–400 
Group C 
(n=8) 
1  430–350 
2  550–280 
3  100–50 
4  150–600 
5  150–100 
6  450–300 
7  50–250 
8  800–650 
 
Table 3: Measurements of mesothelial proliferation, 
mononuclear cell infiltration and macrophage infiltra-
tion where adhesions were most intense in Groups A, B 
and C 
Number of 
rats  
Mesothelial 
proliferation 
score* 
MIC infiltration 
score** 
Macrophage 
infiltration 
score*** 
Group A 
(n=4) 
1  1 1 1 1  1 2 1 1  1 2 2 1 
2  1 1 1 1  1 1 1 1  1 1 1 1 
3  1 1 1 1  1 1 1 1  1 1 1 1 
4  1 2 2 1  1 2 3 1  1 2 2 1 
Group B 
(n=8) 
1  1 2 4 3  1 1 1 1  1 2 1 1 
2  1 1 1 1  3 3 3 3  2 1 1 2 
3  1 1 1 1  1 2 1 1  1 2 1 1 
4  1 4 4 1  1 2 1 1  2 2 1 2 
5  4 4 4 4  2 2 1 1  2 3 1 1 
6  4 4 4 4  1 2 2 1  1 2 2 1 
7  2 4 4 2  2 2 2 1  1 1 1 1 
8  4 3 3 3  3 3 2 1  2 3 1 2 
Group C 
(n=8) 
1  1 2 1 1  1 1 1 1  1 1 1 1 
2  1 2 1 1  1 2 1 1  1 1 1 1 
3  1 2 1 1  1 1 1 1  1 1 1 1 
4  1 1 3 1  1 2 1 1  1 2 1 1 
5  1 1 2 2  1 1 2 1  1 1 2 1 
6  2 3 3 1  2 2 2 1  2 3 3 1 
7  1 3 3 1  1 2 2 1  1 3 3 1 
8  1 3 2 2  1 1 1 2  2 1 2 2 
*1: Pleural surface is completely covered with mesothelium cells, 2: 
Fifty percent of pleural surface is covered with mesothelium cells, 3: 
Less than 50% of the pleural surface is covered with mesothelium 
cells, 4: Absence of mesothelium tissue.  
**1: Mild: Almost no MIC, 2: Moderate: MIC count < 100, 3: Marked: 
MIC count > 100 
***1: Mild: Almost no macrophages, 2: Moderate: Macrophage 
count < 100, 3: Marked: Macrophage count > 100. 
 
 
 
Statistically  significant  differences  were  found 
among all three groups  in terms of mean length of 
adhesion. For mean intensity of adhesion, on the other 
hand, significant differences were noted between the 
Group A and Group B and between the Group B and 
Group C (P<0.05) (Table 4, 5). These findings showed 
macroscopic adhesions in the Group A and Group B, 
while adhesion was not noted in any of the rats in the 
Group C.  
 
 
 
Table 4: Statistical comparison of Group A, Group B and 
Group C by mean adhesion length, mean adhesion score, 
mean mesothelial proliferation score, mean pleural 
thickness, mean mononuclear cell infiltration score and 
mean macrophage infiltration score  
 
 
 
Group A  
 
Group B  
 
Group C  
 
P 
 
Length of adhesion  
(Mean ± SD) 
 
3.0 ± 2.2 
 
10.0 ± 2.0 
 
0.0 ± 0.0 
 
0.000* 
 
Adhesion score 
(Mean ± SD) 
 
1.5 ± 1.0 
 
3.4 ± 0.7 
 
1.0 ± 0.0 
 
0.001* 
Mesothelial pro-
liferation score 
(Mean ± SD) 
 
1.1 ± 0.3 
 
2.7 ± 1.2 
 
1.6 ± 0.4 
 
0.037* 
 
Pleural thickness  
(Mean ± SD) 
 
306.3 ± 
199.4 
 
357.5 ± 
289.2 
 
226.3 ± 
141.8 
 
0.534 
MIC infiltration 
score  
(Mean ± SD) 
 
1.3 ± 0.4 
 
1.7 ± 0.7 
 
1.3 ± 0.3 
 
0.321 
Macrophage infil-
tration score (Mean 
± SD) 
 
1.3 ± 0.3 
 
1.5 ± 0.3 
 
1.4 ± 0.5 
 
0.522 
 
 
Table 5: Statistical comparisons between Group 
A-Group B, Group A-Group C and Group B-Group C  
  Group 
A-Group B 
Group 
A-Group C 
Group 
B-Group C 
Mean adhesion 
length 
p=0.006  p=0.007  p=0.00 
Mean adhesion 
intensity score 
p=0.01  p=0.102  p=0.00 
Mean mesothelial 
proliferation score 
p=0.052  p=0.037  p=0.091 
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DISCUSSION  
This  study  of  an  experimental  intrapleural 
adesion  model  revealed  three  points:  (a)  The  an-
ti-adhesion  effects  of  Prevadh®  was  achieved 
following thoracotomy, and  length of adhesion and 
intensity of adhesion scores revealed better results in 
Group C. (b) The mesothelial cell proliferation scores 
were increased in the Group C. (c) Prevadh® did not 
affect the mean pleural thickness values, mean MIC 
infiltration  score  and  mean  macrophage  infiltration 
score. 
Problems  during  mesothelial  layer  repair  sec-
ondary to tissue damage at the serosal cavities may 
result in adhesion. Abdomen is the body part where 
post-operational adhesions are observed, and requires 
emergency  repeat  surgery  most  commonly.  Adhe-
sions are reported as a sequel in 90% of laparotomies 
[2]. These adhesions lead to increased morbidity and 
mortality and results in significant financial losses. In 
1998, 1.2 billion dollars were spent to cure abdominal 
adhesions just in the USA [8, 9]. Therefore, the major-
ity of studies on prevention of adhesions were con-
ducted by professionals involved in abdominal sur-
geries. There are only a few clinical and experimental 
studies that looked into the prevention of adhesion in 
thoracic surgery. Besides, the increasing numbers of 
recurrent  thoracotomy  cases  and  serious  complica-
tions that develop during and following surgical in-
terventions of these patients have led us to conduct 
this study [10-12]. 
Witnessing the issues with recurrent thoracoto-
mies,  Tanaka  et  al.  demonstrated  that  adhesions 
which develop following thoracotomies may be suc-
cessfully  eliminated  using  hyaluronate-based  ab-
sorbable membran in rats [6]. Getman et al. observed 
no  adhesions  in  patients  who  were  administered 
TachoSil® for bleeding control and air leaks when the 
authors  performed  recurrent  thoracotomy  for  any 
reason, and confirmed the efficacy of TachoSil® as an 
anti-adhesive  agent  by  performing  an  experimental 
rat study [7]. In addition, Ginsburg et al., in two cases 
who  they  performed  two-stage  anterior  spinal  pro-
cedure for correction for severe kyphosis, placed sili-
cone rubber over the vertebra following the first sur-
gery  and  observed  in  the  second  thoracotomy  that 
there was no adhesion between the lung and vertebra 
[13].  
In the present study, the Group B containing rats 
with induced adhesion had longer and more intense 
adhesions compared to the Group A, which only un-
derwent thoracotomy, demonstrating the efficacy of 
the applied adhesion model. On the other hand, in the 
Group C, which included rats with induced adhesion 
and  received  Prevadh®,  no  adhesion  developed 
across the thoracotomy line in any of the rats. An as-
sessment  of  adhesion  length  and  adhesion  score 
yielded significantly lower scores for the Group C. In 
other words, use of Prevadh® prevents adhesion at 
the administration site with a 100% efficacy. No in-
convenience  associated  with  Prevadh®  administra-
tion was experienced throughout the study. It is pos-
sible to achieve firm grasp by wetting the intact sur-
face with saline solution or by applying directly on 
the  bleeding  surface.  This  excludes  a  possible  dis-
placement from the application zone. This may have a 
further potential advantage in that it may prevent air 
leaks  in  lung  surgeries.  However,  it  should  be 
demonstrated in an experimental study. 
In addition to confirming anti-adhesion agents’ 
clinical benefits, risk-benefit ratio associated with use 
of these agents should also be established before they 
may find routine use in surgical settings, since use of 
these state-of-art and expensive products will present 
an additional, significant financial burden on both the 
patient  and  payers.  On  the  other  hand,  increasing 
number of patients requiring recurrent thoracotomy 
and complications that develop during interventions 
to eliminate adhesions makes it necessary to use an-
ti-adhesion agents in selected patients in the thoracic 
surgeries.  What  is  important  here  is  to  develop 
well-established  criteria  to  determine  these  selected 
patients, and the indications for use of anti-adhesion 
agents in thoracic surgery. Currently, no relevant data 
is  available  in  the  literature.  We  believe  that  these 
agents  should  be  administered  to  all  patients  who 
underwent thoracotomy during the early phase of life, 
those for whom two-stage lung or thoracic wall sur-
gery is planned and in cases of metastatic cancers of 
the lungs where there is a high risk for recurrent sur-
gery. These agents may also be recommended for pa-
tients with low respiratory reserve or those prone to 
bleeding  in  order  to  prevent  possible  air  leaks  and 
bleeding complications that may result from recurrent 
thoracotomy.  
Another important question is how to choose the 
correct  anti-adhesion  agent.  An  ideal  anti-adhesion 
agent should not hinder wound-healing, not predis-
pose the patient to infection, prevent fibrosis, main-
tain its presence in the tissue throughout the natural 
healing  process,  and  not  cause  foreign  matter  reac-
tion.  Also,  it  should  be  easily  eliminated  from  the 
body  after  healing,  and  should  also  be  usable  for 
thoracoscopic  surgeries.  In  addition,  anti-adhesion 
agents which can prevent bleeding and air leaks often 
observed following lung resections are expected to be 
more advantageous in the thoracic surgery.  Int. J. Med. Sci. 2011, 8 
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Limitations of this study include the low number 
of rats and the lack of use of various  anti-adhesion 
agents. Our findings are also based on the result of 
macroscopic  and  histopathological  examinations. 
However,  biochemical  data  would  elucidate 
physiopathological  changes  associated  with  pleural 
adhesion  and  the  effects  of  Prevadh®.  Experiments 
involving a higher number of rats especially in Group 
A, and different anti-adhesion agents may yield more 
comprehensive results.  
CONCLUSION  
The present study demonstrated in a rat model 
that Prevadh® was an efficient anti-adhesion agent. 
We believe that using Prevadh® in the  presence  of 
right  indications  will  reduce  adhesions  following 
thoracotomy. However, as in any experimental study, 
this conclusion should be supported by clinical trials. 
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